DiscoverThe Prostate Health Podcast83: The Time is Now: Germline Genetic Test to Address all Prostate Cancer-Specific Needs (ProstateNow) with Paul M. Yonover, MD
83: The Time is Now: Germline Genetic Test to Address all Prostate Cancer-Specific Needs (ProstateNow) with Paul M. Yonover, MD

83: The Time is Now: Germline Genetic Test to Address all Prostate Cancer-Specific Needs (ProstateNow) with Paul M. Yonover, MD

Update: 2023-04-20
Share

Description

We are excited to partner with GoPath Diagnostics for today’s podcast and have Dr. Paul Yonover join us on the show to bring listeners up to speed on the newly-available comprehensive germline test called ProstateNow that addresses all patient needs specific to prostate cancer.

Dr. Paul Yonover is a board-certified urologist who completed his residency programs in surgery and urology at Loyola University Medical Center. Dr. Yonover has done extensive research in urology and has published in numerous clinical journals. He is the Chief Analytics Officer and Director of Clinical Research for Uro Partners in Chicago, Illinois. In addition, he is currently a Clinical Assistant Professor of Urology at the University of Illinois Chicago College of Medicine and a Chief of Urology at Advocate Illinois Masonic Hospital and Amita Presence St. Joseph Hospital.

Tune in to find out what the ProstateNow test is, how it works, who can benefit from it, and how urologists are incorporating it into their clinical practices!

Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation.

Show highlights:

  • Dr. Yonover explains how he approaches germline testing related to prostate cancer in his practice.

  • Dr. Yonover explains the importance of identifying the rare pathogenic mutations that are risk factors for disease.

  • Why is family history a risk factor for prostate cancer?

  • What should patients be advised to do if they have a pathogenic mutation?

  • Dr. Yonover explains what rare pathogenic mutations are.

  • Some of the historic barriers urologists and oncologists have had in integrating prostate cancer genetic testing into their practices.

  • How did Dr. Yonover’s practice overcome the barriers and incorporate germline testing?

  • Dr. Yonover dives into what the ProstateNow test is and how it works.

  • Dr. Yonover shares some important things to bear in mind regarding germline testing.

Links:

Follow Dr. Pohlman on Twitter and Instagram - @gpohlmanmd

Get your free

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

83: The Time is Now: Germline Genetic Test to Address all Prostate Cancer-Specific Needs (ProstateNow) with Paul M. Yonover, MD

83: The Time is Now: Germline Genetic Test to Address all Prostate Cancer-Specific Needs (ProstateNow) with Paul M. Yonover, MD

Garrett Pohlman, MD